US3846470A - Derivatives of 3-benzoyl-2-({62 -hydroxyphenethylamino)-propionitrile - Google Patents
Derivatives of 3-benzoyl-2-({62 -hydroxyphenethylamino)-propionitrile Download PDFInfo
- Publication number
- US3846470A US3846470A US00239359A US23935972A US3846470A US 3846470 A US3846470 A US 3846470A US 00239359 A US00239359 A US 00239359A US 23935972 A US23935972 A US 23935972A US 3846470 A US3846470 A US 3846470A
- Authority
- US
- United States
- Prior art keywords
- stands
- group
- member selected
- propionitrile
- nucleus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 claims abstract description 18
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 125000003545 alkoxy group Chemical group 0.000 abstract description 8
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 7
- 150000002367 halogens Chemical class 0.000 abstract description 7
- 239000001257 hydrogen Substances 0.000 abstract description 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 6
- 125000000217 alkyl group Chemical group 0.000 abstract description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 6
- 229910052736 halogen Inorganic materials 0.000 abstract description 6
- 230000002490 cerebral effect Effects 0.000 abstract description 5
- 150000002576 ketones Chemical class 0.000 abstract description 5
- 230000000916 dilatatory effect Effects 0.000 abstract description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract description 4
- 125000002947 alkylene group Chemical group 0.000 abstract description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract description 3
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 239000000243 solution Substances 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 15
- 238000002844 melting Methods 0.000 description 15
- 230000008018 melting Effects 0.000 description 15
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 125000004193 piperazinyl group Chemical group 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 150000001805 chlorine compounds Chemical class 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- NYZXYTPHEHSYNE-UHFFFAOYSA-N 2-(4-chlorobenzoyl)prop-2-enenitrile Chemical compound ClC1=CC=C(C(=O)C(=C)C#N)C=C1 NYZXYTPHEHSYNE-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 2
- BUHYMJLFRZAFBF-UHFFFAOYSA-N 3,4,5-trimethoxybenzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC(OC)=C1OC BUHYMJLFRZAFBF-UHFFFAOYSA-N 0.000 description 2
- DSLXRANAPTYXPW-UHFFFAOYSA-N 3-chloro-1-(4-chlorophenyl)prop-2-en-1-one Chemical compound ClC=CC(=O)C1=CC=C(Cl)C=C1 DSLXRANAPTYXPW-UHFFFAOYSA-N 0.000 description 2
- KZHCVYMQWVJNEY-UHFFFAOYSA-N 3-hydroxy-1-phenylprop-2-en-1-one Chemical class OC=CC(=O)C1=CC=CC=C1 KZHCVYMQWVJNEY-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 125000005521 carbonamide group Chemical group 0.000 description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 2
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- -1 potassium carboxylate Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- NUMXHEUHHRTBQT-AATRIKPKSA-N 2,4-dimethoxy-1-[(e)-2-nitroethenyl]benzene Chemical compound COC1=CC=C(\C=C\[N+]([O-])=O)C(OC)=C1 NUMXHEUHHRTBQT-AATRIKPKSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- XEFRNCLPPFDWAC-UHFFFAOYSA-N 3,4,5-trimethoxyaniline Chemical compound COC1=CC(N)=CC(OC)=C1OC XEFRNCLPPFDWAC-UHFFFAOYSA-N 0.000 description 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 1
- 101100515517 Arabidopsis thaliana XI-I gene Proteins 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 101100010166 Mus musculus Dok3 gene Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 101000962654 Vespa orientalis Mastoparan Proteins 0.000 description 1
- 150000008062 acetophenones Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- CVVIJWRCGSYCMB-UHFFFAOYSA-N hydron;piperazine;dichloride Chemical compound Cl.Cl.C1CNCCN1 CVVIJWRCGSYCMB-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- VKDBLXQITPBAAG-UHFFFAOYSA-N propanenitrile;hydrochloride Chemical compound Cl.CCC#N VKDBLXQITPBAAG-UHFFFAOYSA-N 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
Definitions
- the present invention relates to new pharmacologically valuable ketone derivatives exhibiting a distinct dilatory action on the cerebral vessels and which have the general formula and their pharmaceutically acceptable acid addition salts, wherein R stands for a member selected from the group consisting of CN, CONHg, COOH. COONa and COOK, R stands for a member selected from the group consisting of and X stands for alkylene having I to 4, carbon atoms, Y stands for a member selected from the group consisting of OCO- and CONH,
- R 3 and R each stand for a member selected from the group consisting of hydrogen and alkyl having I to 6 carbon atoms,
- R stands for a member selected from the group consisting of hydrogen and OH
- the nucleus 1 may have 1 to 3 alkoxy, halogen,
- the nucleus 11 may have 1 to 3 alkoxy, halogen or alkyl substituents,
- the nucleus III may be substituted by 1 to 3 methoxy groups and to processes for producing said ketone derivatives.
- R stands for -N N X Y -@-or f CH 1 X stands for alkylene having 1 to 4 carbon atoms
- Y stands for OCO- or CONH R and R each stand for hydrogen or alkyl having up to 6 carbon atoms, and
- R stands for hydrogen, or OH
- nucleus I may have I to 3 alkoxy, halogen, alkyl or nitro substituents,
- nucleus Il may have 1 to 3 alkoxy, halogen or alkyl substituents, and
- the nucleus III may be substituted by l to 3 methoxy groups.
- the compounds of general formula I contain at least one basic nitrogen atom and may consequently form or be formed as salts, in particular hydrohalides, and the invention extends to such acid addition salts, where 'pharmaceutically acceptable.
- Preferred halogen substituents for the nucleus I and- /or the nucleus II are fluorine, chlorine and bromine.
- Preferred alkyl substituents of the nucleus I and of the nucleus II contain 1 to 8 carbon atoms.
- Preferred alkoxy substuents are methoxy groups.
- the compounds of formula I may be prepared, for example,
- Xl may be 7 7 prepared, as far as they are not yet described in literature, according to known per se methods.
- the compounds of the present invention and their pharmaceutically acceptable salts may be employed together with pharamaceutically acceptable diluents or carriers for the preparation of pharmaceutical formulations such as tablets, dragees, suppositories, capsules, solutions, suspensions or emulsions.
- These pharmaceutical preparations may also contain other therapeutically active substances.
- hydrochloride (a-methyl-B-hydroxy- 2.0 14 l1 l0 +25l+50 l7 phenethylamino)-pt'opioi.v.
- the 2',3,4'trimethoxybenzoylacrylic acid required as starting material may be prepared as follows:
- the 2',3',4'-trimethoxybenzoylacrylic acid amide required as starting material may be prepared as followsr 8 g. 2',3,4'-trimethoxybenzoylacrylonitril are dissolved in 40 c.c. concentrated sulfuric acid and heated etheric hydrochloric acid, and the precipitate is sucked off and washed several times with ether. Subsequently, it is treated with water, whereby first muddy mass is formed which solidifies while further standing.
- the solid product is sucked off, suspended in dilute soda solution and immediately extracted three times with chloroform.
- the chloroform solution is washed with water, dried and concentrated in vacuo.
- the resinous residue is dissolved in anhydrous dioxane, admixed with etheric hydrochloric acid and the separated precipitate is sucked off and washed with ether.
- the residue is then stirred for one hour in about 30 c.c. water, whereby first a muddy mass is again formed which solidifies after a short while.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US359442A US3864344A (en) | 1971-04-02 | 1973-05-11 | 3-(Benzoyl)-2-(4{40 -anilino carbonyl or benzoxy-alkyl piperazino)-propionitriles |
US359440A US3867389A (en) | 1972-03-29 | 1973-05-11 | Alpha-(n-benzoyloxy and phenylamino alkyl-piperazino)-beta-benzoyl-propionic acid derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19712116293 DE2116293A1 (de) | 1971-04-02 | 1971-04-02 | Ketonderivate und Verfahren zu ihrer Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
US3846470A true US3846470A (en) | 1974-11-05 |
Family
ID=5803749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00239359A Expired - Lifetime US3846470A (en) | 1971-04-02 | 1972-03-29 | Derivatives of 3-benzoyl-2-({62 -hydroxyphenethylamino)-propionitrile |
Country Status (11)
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3980643A (en) * | 1974-01-04 | 1976-09-14 | Hokuriku Pharmaceutical Co., Ltd. | Novel piperazine- and homopiperazine-monoalkanol esters and a process of production thereof |
DE3214082A1 (de) * | 1981-04-17 | 1982-11-04 | Roussel-Uclaf, 75007 Paris | Neue derivate von phenyl-aliphatischen carbonsaeuren, deren herstellung, deren verwendung als arzneimittel und die sie enthaltenden zusammensetzungen |
US4384137A (en) * | 1980-09-04 | 1983-05-17 | Societe Francaise Hoechst | Process for preparation of hydroxyarylglyoxylic acids and their alkaline salts, and application thereof to preparation of sodium parahydroxyphenylglyoxylate |
US4402978A (en) * | 1980-04-24 | 1983-09-06 | Roussel-Uclaf | Gastro-protecting activity of substituted derivatives of 4-phenyl-4-oxo-2-hydroxy-butanoic acid |
US4436752A (en) | 1981-04-17 | 1984-03-13 | Roussel Uclaf | Treatment of gastric and gastro-duodenal disorders with derivatives of phenyl aliphatic carboxylic acids |
US4454155A (en) * | 1981-10-22 | 1984-06-12 | Roussel Uclaf | Pharmaceutical compositions containing a mono-substituted derivative of 4-phenyl-4-oxobuten-2-oic acid, and methods of using them in treating gastric and gastroduodenal ailments |
US4473583A (en) * | 1981-10-22 | 1984-09-25 | Roussel Uclaf | Compositions containing certain derivatives of 4-phenyl-4-oxobuten-2-oic acid and methods of treatment using them |
US4483868A (en) * | 1980-04-24 | 1984-11-20 | Roussel Uclaf | Gastro-protecting activity |
US4486429A (en) * | 1981-10-22 | 1984-12-04 | Roussel Uclaf | Amino derivatives of 4-phenyl 4-oxobuten-2-oic acid, pharmaceutical compositions containing them, and methods for preparing and therapeutically using them |
US4594443A (en) * | 1983-08-25 | 1986-06-10 | Roussel-Uclaf | Derivatives of 4-phenyl-4-oxo-buten-2-oic acid and therapeutic use thereof |
US4751324A (en) * | 1985-06-13 | 1988-06-14 | Henkel Kommanditgesellschaft Auf Aktien | Benzoyl alanine compounds and their use as corrosion inhibitors |
US4814348A (en) * | 1983-01-24 | 1989-03-21 | Roussel Uclaf | Therapeutic compositions containing derivatives of acrylic acid having an oxygen-containing heterocycle, therapeutic treatment therewith and new compounds |
US5234894A (en) * | 1991-03-29 | 1993-08-10 | Tokuyama Soda Kabushiki Kaisha | Carbonyl acetonitrile derivative and herbicide containing it as an active component |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1574019A (en) | 1977-01-14 | 1980-09-03 | Joullie International Sa | Therapeutically useful 3,4,5-trimethoxybenzene derivatives |
DE4443465A1 (de) * | 1994-12-07 | 1996-06-13 | Chemie Linz Deutschland | Verfahren zur Herstellung von (S,S)-(N-(1-Ethoxycarbonyl-3-oxo-3-phenylpropyl)-alanin)-(phenylmethyl)ester |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3225095A (en) * | 1962-03-31 | 1965-12-21 | Degussa | N-aryl-substituted-propan-(1)-ones and -ols of arylaminoalkanols and salts thereof |
US3646145A (en) * | 1967-06-29 | 1972-02-29 | Degussa | N-(1-hydroxy-1-phenyl-ethyl amino)-propiophenones |
-
1971
- 1971-04-02 DE DE19712116293 patent/DE2116293A1/de active Pending
-
1972
- 1972-03-17 NL NL7203630A patent/NL7203630A/xx unknown
- 1972-03-28 AR AR241197A patent/AR192920A1/es active
- 1972-03-29 US US00239359A patent/US3846470A/en not_active Expired - Lifetime
- 1972-03-30 GB GB15036/72*2A patent/GB1346029A/en not_active Expired
- 1972-03-30 DD DD161945A patent/DD96702A5/xx unknown
- 1972-03-31 SU SU1768202A patent/SU439983A3/ru active
- 1972-03-31 CS CS674*[A patent/CS159702B2/cs unknown
- 1972-03-31 AT AT282172A patent/AT316522B/de not_active IP Right Cessation
- 1972-03-31 FR FR7211561A patent/FR2132354B1/fr not_active Expired
- 1972-03-31 BE BE781544A patent/BE781544A/xx unknown
- 1972-03-31 AT AT460773A patent/AT315857B/de not_active IP Right Cessation
- 1972-03-31 AT AT460873A patent/AT315185B/de not_active IP Right Cessation
- 1972-03-31 CS CS2198A patent/CS159701B2/cs unknown
- 1972-03-31 CS CS675*[A patent/CS159703B2/cs unknown
-
1973
- 1973-02-01 AR AR246385A patent/AR199200A1/es active
- 1973-02-01 AR AR246384A patent/AR193462A1/es active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3225095A (en) * | 1962-03-31 | 1965-12-21 | Degussa | N-aryl-substituted-propan-(1)-ones and -ols of arylaminoalkanols and salts thereof |
US3646145A (en) * | 1967-06-29 | 1972-02-29 | Degussa | N-(1-hydroxy-1-phenyl-ethyl amino)-propiophenones |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3980643A (en) * | 1974-01-04 | 1976-09-14 | Hokuriku Pharmaceutical Co., Ltd. | Novel piperazine- and homopiperazine-monoalkanol esters and a process of production thereof |
US4483868A (en) * | 1980-04-24 | 1984-11-20 | Roussel Uclaf | Gastro-protecting activity |
US4402978A (en) * | 1980-04-24 | 1983-09-06 | Roussel-Uclaf | Gastro-protecting activity of substituted derivatives of 4-phenyl-4-oxo-2-hydroxy-butanoic acid |
US4384137A (en) * | 1980-09-04 | 1983-05-17 | Societe Francaise Hoechst | Process for preparation of hydroxyarylglyoxylic acids and their alkaline salts, and application thereof to preparation of sodium parahydroxyphenylglyoxylate |
DE3214082A1 (de) * | 1981-04-17 | 1982-11-04 | Roussel-Uclaf, 75007 Paris | Neue derivate von phenyl-aliphatischen carbonsaeuren, deren herstellung, deren verwendung als arzneimittel und die sie enthaltenden zusammensetzungen |
US4436752A (en) | 1981-04-17 | 1984-03-13 | Roussel Uclaf | Treatment of gastric and gastro-duodenal disorders with derivatives of phenyl aliphatic carboxylic acids |
US4450292A (en) * | 1981-04-17 | 1984-05-22 | Roussel Uclaf | Derivatives of phenyl aliphatic carboxylic acids, and use thereof in treating gastric and gastro-duodenal ailments |
US4454155A (en) * | 1981-10-22 | 1984-06-12 | Roussel Uclaf | Pharmaceutical compositions containing a mono-substituted derivative of 4-phenyl-4-oxobuten-2-oic acid, and methods of using them in treating gastric and gastroduodenal ailments |
US4473583A (en) * | 1981-10-22 | 1984-09-25 | Roussel Uclaf | Compositions containing certain derivatives of 4-phenyl-4-oxobuten-2-oic acid and methods of treatment using them |
US4486429A (en) * | 1981-10-22 | 1984-12-04 | Roussel Uclaf | Amino derivatives of 4-phenyl 4-oxobuten-2-oic acid, pharmaceutical compositions containing them, and methods for preparing and therapeutically using them |
US4814348A (en) * | 1983-01-24 | 1989-03-21 | Roussel Uclaf | Therapeutic compositions containing derivatives of acrylic acid having an oxygen-containing heterocycle, therapeutic treatment therewith and new compounds |
US4594443A (en) * | 1983-08-25 | 1986-06-10 | Roussel-Uclaf | Derivatives of 4-phenyl-4-oxo-buten-2-oic acid and therapeutic use thereof |
US4751324A (en) * | 1985-06-13 | 1988-06-14 | Henkel Kommanditgesellschaft Auf Aktien | Benzoyl alanine compounds and their use as corrosion inhibitors |
US5234894A (en) * | 1991-03-29 | 1993-08-10 | Tokuyama Soda Kabushiki Kaisha | Carbonyl acetonitrile derivative and herbicide containing it as an active component |
Also Published As
Publication number | Publication date |
---|---|
BE781544A (fr) | 1972-10-02 |
AR193462A1 (es) | 1973-04-23 |
DD96702A5 (enrdf_load_stackoverflow) | 1973-04-05 |
AR192920A1 (es) | 1973-03-21 |
NL7203630A (enrdf_load_stackoverflow) | 1972-10-04 |
AR199200A1 (es) | 1974-08-14 |
DE2116293A1 (de) | 1972-10-19 |
GB1346029A (enrdf_load_stackoverflow) | 1974-02-06 |
SU439983A3 (ru) | 1974-08-15 |
FR2132354A1 (enrdf_load_stackoverflow) | 1972-11-17 |
CS159702B2 (enrdf_load_stackoverflow) | 1975-01-31 |
FR2132354B1 (enrdf_load_stackoverflow) | 1975-04-25 |
AT315185B (de) | 1974-05-10 |
CS159703B2 (enrdf_load_stackoverflow) | 1975-01-31 |
CS159701B2 (enrdf_load_stackoverflow) | 1975-01-31 |
AT315857B (de) | 1974-06-10 |
AT316522B (de) | 1974-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3846470A (en) | Derivatives of 3-benzoyl-2-({62 -hydroxyphenethylamino)-propionitrile | |
US4127606A (en) | Substituted sulfonamides having antiinflammatory activity | |
JPH0572384B2 (enrdf_load_stackoverflow) | ||
JPH0272136A (ja) | ナフタレン誘導体、その製法及びその合成中間体 | |
ES2276547T3 (es) | Derivados de 2-(n-cianoimino)tiazolidin-4-ona. | |
US4866091A (en) | Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same | |
CA1276938C (en) | Arylacetic acid derivatives | |
DE69333285T2 (de) | 2-heterozyklisch-5-hydroxy-1,3-pyrimidinen verwendbar als entzündungswidrigesmittel | |
US2722529A (en) | Amides of certain l-amevoalkyl-x-phenyl | |
US4129656A (en) | Thiazolidine derivatives, salidiuretic compositions and methods of effecting salidiuresis employing them | |
US3076817A (en) | New j-amino-thiophene-z | |
US2912460A (en) | Basically substituted carboxylic acid amides and a process of preparing them | |
US3816443A (en) | 4-(benzothiazol-2-yl)fluoro phenyl-acetic acids | |
KR20030077558A (ko) | 트로폴론 유도체 | |
EP0424194B1 (en) | Benzanilide derivatives and their use as anti-atherosclerotic agents | |
US4325964A (en) | Phenylamidine derivatives | |
US3772308A (en) | Cyclopentanecetamides and cyclopentaneacetonitriles | |
US2636037A (en) | 2-amino-4-piperidinoethyl-thiazole | |
JPS6310777A (ja) | ピペラジンアセトアミド誘導体 | |
JPH0667915B2 (ja) | 5−トリフルオロアシルアミノ−2−アリール オキサゾール | |
US3867389A (en) | Alpha-(n-benzoyloxy and phenylamino alkyl-piperazino)-beta-benzoyl-propionic acid derivatives | |
US3389170A (en) | 3-acylamino-2, 4, 6-triiodo-benzoic acids | |
US3694489A (en) | Pharmacologically active esters and amides of n-{8 3-trifluoromethylphenyl{9 -anthranilic acid | |
US4029787A (en) | Basically substituted 3-sulfamoylbenzoic acid derivatives and process for their preparation | |
SU1493105A3 (ru) | Способ получени гетероциклических соединений |